• Taking the Fight to the Molecular Level: The Human Genome Is Our Greatest Weapon

    The molecular tumor board brings together multidisciplinary groups to analyze a patient’s tumor cells and healthy cells, giving each patient a new means to fight for their own health.

  • Breast Team Receives Prestigious American College of Surgeons’ NAPBC Accreditation

    The National Accreditation Program for Breast Centers recognizes health-care providers that are dedicated to high standards of care and have ambitious goals for quality improvement.

  • UA Cancer Center Team Targets Tumor Suppressor to Treat ‘Triple-Negative’ Breast Cancer

    A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast tumors, producing new therapeutic candidates for this difficult-to-treat cancer.

Taking the Fight to the Molecular Level: The Human Genome Is Our Greatest Weapon

The molecular tumor board brings together multidisciplinary groups to analyze a patient’s tumor cells and healthy cells, giving each patient a new means to fight for their own health.

Breast Team Receives Prestigious American College of Surgeons’ NAPBC Accreditation

The National Accreditation Program for Breast Centers recognizes health-care providers that are dedicated to high standards of care and have ambitious goals for quality improvement.

UA Cancer Center Team Targets Tumor Suppressor to Treat ‘Triple-Negative’ Breast Cancer

A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast tumors, producing new therapeutic candidates for this difficult-to-treat cancer.

News Stories

The molecular tumor board brings together multidisciplinary groups to analyze a patient’s tumor cells and healthy cells, giving each patient a new means to fight for their own health.

The National Accreditation Program for Breast Centers recognizes health-care providers that are dedicated to high standards of care and have ambitious goals for quality improvement.

A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast cancer tumors, producing several new therapeutic candidates for this difficult-to-treat cancer.